Skip to content

Thursday, December 24th, 2009

Bioreactor increases interleukin-12 production in genetically modified tobacco

December 4, 2008 by Grace Ibay  
Filed under Health

Comments Off

Bioreactor increases interleukin-12 production in genetically modified tobacco

This new study is along the lines of vaccine-producing bananas.
One of the best uses of genetic engineering of plants is producing rare proteins with medical use in larger quantities. Interleukin-12 is one of those proteins that our bodies produce in regulated quantities, but is very essential for the function of the immune system. Certain immune diseases are the result of having either too little or too much interleukin-12. If scientists can harness enough of the protein for research and therapeutic development, then perhaps certain diseases can be controlled better.
New findings published in the journal Biotechnology and Bioengineering found …read more


About Us | Advertise with us | Blog for Blisstree | Privacy Policy | Terms of Use
Get This Theme | Sitemap


All content is Copyright © 2005-2009 b5media. All rights reserved.